NIFTY23,4170.05%
SENSEX74,3600.02%
BANKNIFTY54,3080.22%
NIFTY IT29,3010.29%
PHARMA24,1780.38%
AUTO26,1440.20%
FMCG48,2160.19%
METAL13,4360.73%
REALTY764.600.26%
ENERGY40,4460.62%
NIFTY23,4170.05%
SENSEX74,3600.02%
BANKNIFTY54,3080.22%
NIFTY IT29,3010.29%
PHARMA24,1780.38%
AUTO26,1440.20%
FMCG48,2160.19%
METAL13,4360.73%
REALTY764.600.26%
ENERGY40,4460.62%

BHEL Shares Come Under Pressure After UBS Downgrade

Shares of Bharat Heavy Electricals Ltd (BHEL) came under pressure on Thursday after global brokerage UBS downgraded the stock to Neutral from Buy, citing a more balanced risk-reward profile following the stock's strong run over the past year. The stock fell as much as 5.4 percent during the session to Rs 384.5 before recovering some losses.

In the late afternoon trade, the stock was trading at Rs 391.95, down 3.5 percent for the day. This decline comes despite UBS raising its target price to Rs 460 per share from Rs 375, implying an upside of over 13 percent from yesterday's close. The brokerage's decision to downgrade the stock is based on the fact that BHEL has outperformed the Nifty by around 60 percent over the past 12 months, leaving a more balanced risk-reward profile despite continued confidence in the company's earnings outlook.

The downgrade by UBS is significant, as it reflects the brokerage's assessment of the stock's performance and its future prospects. However, it is worth noting that the stock's strong run over the past year has left it with a more balanced risk-reward profile, according to UBS.

Read also: Arm Soars to Become One of Market's Most Valuable Stocks, Reaching $218 Billion Market Capitalization

Target PricePrevious Target PriceUpside Potential
Rs 460Rs 375Over 13 percent

Note: The table above highlights the target price increase by UBS and the corresponding upside potential for BHEL investors.

Investor Takeaway

Investors should be cautious with BHEL shares following the downgrade to Neutral by UBS.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.